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Abstract
Epidemiological studies have repeatedly found that whole-grain (WG) cereal foods reduce the risk of several lifestyle-related diseases,
though consistent clinical outcomes and mechanisms are elusive. To compare the effects of a WG-rich diet with a matched refined-
grain (RG) diet on plasma biomarkers and bowel health parameters, seventeen healthy subjects (eleven females and six males) completed
an exploratory cross-over study with a 2-week intervention diet based on either WG- or RG-based foods, separated by a washout of at least
5 weeks. Both diets were the same except for the use of WG (150 g/d) or RG foods. Subjects undertook a 4 h postprandial challenge on day
8 of each intervention diet. After 2 weeks, the WG diet tended to decrease plasma total and LDL-cholesterol (both P¼0·09), but did not
change plasma HDL-cholesterol, fasting glucose, C-reactive protein or homocysteine compared with the RG diet. Plasma betaine and alkyl-
resorcinol concentrations were elevated after 1 week of the WG diet (P¼0·01 and P,0·0001, respectively). Clostridium leptum populations
in faeces were increased after the WG diet, along with a trend for decreased faecal water pH (P¼0·096) and increased stool frequency
(P,0·0001) compared with the RG diet. A short controlled intervention trial with a variety of commercially available WG-based products
tended to improve biomarkers of CVD compared with a RG diet. Changes in faecal microbiota related to increased fibre fermentation and
increased plasma betaine concentrations point to both fibre and phytochemical components of WG being important in mediating any
potential health effects.
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Epidemiological studies have pointed to diets rich in whole-
grain (WG) cereal foods reducing the risk of many diet-related
diseases, including CVD(1,2), diabetes(3), obesity, the metabolic
syndrome(4) and some cancers(5), with similar results being
found across many populations. The mechanisms that have
been proposed to underlie the reduction in disease risk
revolve around the fibre and phytochemical content of WG
compared with their refined counterparts(6,7). In the published
literature, a number of interventions based on WG cereal
diets have found that WG lower plasma total and
LDL-cholesterol(8–11), blood pressure(12–14), improve insulin
parameters(15–17) and improve markers of bowel func-
tion(18,19). In most cases, these studies have been carried out
on people already at risk of disease (e.g. overweight/obesity,
hypercholesterolaemia, hyperinsulinaemia). Often these inter-
vention studies have used specially prepared foods based on a
single cereal grain (e.g. rye or barley), rather than WG foods
that are readily available for consumers, and endpoints
generally only span standard blood clinical chemistry
measurements. Additionally, human intervention studies
have not always found clear results from feeding WG cereals
on markers of CVD risk(20–22), which has led to some discus-
sion about the acute impact of a WG diet(23).
In addition to variable results from intervention studies,
mechanisms of how a WG diet may improve health have
also been unclear. While dietary fibre may explain many
potential benefits of WG(24), epidemiological research has
often found benefits for CVD even when correcting for fibre
intake, suggesting that other components in WG may also
play a role(25). Of recent interest is the role of glycine betaine
(betaine), a methyl donor found in high concentrations in WG
wheat- and rye-based foods(26,27). Supply of a higher amount
*Corresponding author: A. B. Ross, fax þ41 21 785 9486, email alastair.ross@rdls.nestle.com
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of betaine may be an additional mechanism for the reduction
in CVD risk due to WG intake, primarily via its role in the
conversion of the cardiovascular risk factor homocysteine to
methionine(28,29).
One of the goals of dietary recommendations for WG cer-
eals is to get healthy people to replace servings of refined
grains (RG; cereal grains with the bran and germ removed
by milling) with WG products in order to reduce the risk of
CVD(30), though few intervention studies have specifically
compared the effect of matched WG foods with RG foods in
healthy subjects(14,21). In order to better understand some of
the possible mechanisms behind the potential benefits of
replacing RG with WG foods, we designed a controlled,
exploratory study to compare the short-term impact of a diet
rich in commercially available WG cereal products with a
diet rich in RG cereal products on parameters related to cardi-
ovascular and gastrointestinal health in healthy subjects.
Materials and methods
Study design
The study was designed as a cross-over trial to compare the
effect of a diet rich in WG with a diet rich in RG. After a
1-week lead-in where subjects were asked not to consume
any WG foods (controlled using diaries and plasma alkylresor-
cinols(31)) in order to have a similar baseline with regard to WG
intake, subjects were randomly assigned to either a WG or RG
diet for 2 weeks. This diet was controlled with all foods being
supplied by the study centre. After the 2-week intervention
period, subjects were asked not to consume any WG foods (as
for the lead-in) for 2 weeks in order to monitor how long any
changes due to the intervention diet lasted (post-intervention
period). After a washout period of 5–7 weeks between the
end of the post-intervention period and the start of the next
lead-in, the subjects repeated the same protocol, but ate the
other diet during the intervention period (Fig. 1). At the start
of the study and at 1-week intervals during the following 5
weeks of the study, blood and 24 h urine samples were
collected (total of six time points). Additionally, spot faecal
collections (first stool passed during the day) were carried out
at baseline and after the 2-week intervention diet period.
Because changes due to the diets may not be evident in fasting
plasma samples, a postprandial substudy was carried out. On
day 8 of both intervention diets, subjects consumed either a
WG breakfast cereal (shredded wheat) or a RG breakfast
cereal (cornflakes), appropriate to the diet they were currently
following. Subjects gave blood samples at 0, 60, 120, 180 and
240 min after the breakfast meal (Fig. 1). The present study
was conducted according to the guidelines laid down in the
Declaration of Helsinki, and all procedures involving human
subjects were approved by the Ethical Committee of the
Lausanne Region, Vaud Canton, Switzerland. Written informed
consent was obtained from all subjects. The study was carried
out from February 2008 to December 2008.
Subjects
A total of twenty-two subjects were recruited to the study.
Written informed consent was obtained from each subject, and
selection took place following a medical questionnaire and con-
firmation of adherence to inclusion/exclusion criteria (healthy
(normal blood lipid panel, BMI 19–28 kg/m2, no chronic or
recent illness, no recent use of antibiotics or medication and
non-smokers), between 20 and 50 years old and low habitual
WG intake (,30 g/d, as determined by an FFQ(31))).
Lead-in
Lead-in
WG diet
RG diet
PI-diet
PI-diet
Phase 1: 5 weeks Washout (5–7 weeks)
Breakfast 60
min
120
min
180
min
Post-prandial sub-study
240
min
P
PP
1 week 1 week 1 week 1 week 1 week
Lead-in WG diet PI-diet
P
1 week 1 week 1 week 1 week 1 week
1 week 1 week 1 week 1 week 1 week
Lead-in
RG diet
PI-diet
Phase 2: 5 weeks
1 week 1 week 1 week1 week 1 week
Fig. 1. Study design. During the first intervention diet period, subjects ate either a diet rich in whole-grain (WG) cereals or a diet rich in refined-grain (RG) cereals.
During the second intervention diet period, they ate the diet they had not eaten during the previous period. ‘PI diet’ is the 2-week post-intervention diet when sub-
jects were asked not to consume any whole grains. O, Sampling points; ‘P’, when the postprandial sampling took place on day 8 of each 14 d dietary intervention.
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Study foods
Foods used in the study were all commercially available from
Nestle´ SA worldwide or purchased from supermarkets
(Lausanne, Switzerland and Huskvarna, Sweden). WG,
energy, protein, fat, carbohydrate and fibre content were
determined from the declared ingredient and nutrient compo-
sitions. The WG component of foods was assumed to have all
three major anatomical fractions of the cereal grain (bran,
germ and endosperm) in the same proportions found natu-
rally. Cereal foods were also analysed for alkylresorcinol(32)
and betaine(27) content.
WG and RG menus were designed to supply a similar total
energy intake, using cereal-based foods as the main source of
carbohydrates (Table 1). Target daily energy intake was 8·5 MJ
(2032 kcal) for the RG diet and 8·8 MJ (2107 kcal) for the WG
diet. Bread (WG or RG wheat depending on the diet) was sup-
plied with lunch and dinner, and was used as a discretionary
food to make it easier for subjects to eat more or less depend-
ing on their individual energy requirements. Seven different
daily menus were devised for each of the WG and RG diets,
with each menu being repeated twice over the 2-week inter-
vention diet period. A wide range of different WG and RG
foods were used in the study to help avoid subject fatigue
with the diet. It was not possible to obtain exact equivalent
WG v. RG cereal foods as RG equivalents were not readily
available (e.g. WG oats v. RG oats), but efforts were made
to match equivalent cereals where possible. Overall, the WG
diet contained 64 % WG wheat, 13 % WG oats and 9 %
brown rice, with the rest from barley and rye, while the RG
diet contained 66 % refined wheat, 27 % white rice and 8 %
refined maize. The average prescribed daily WG intake
during the WG diet was 150 g WG/d on a dry weight basis.
The average prescribed total cereal intake was 277 g for the
RG diet and 275 g for the WG diet (WG and RG ingredients
combined, also dry weight).
During the intervention phases, meals were either eaten in a
dining room at the metabolic unit of the Nestle´ Research
Centre, or provided pre-packaged for preparation at home.
Compliance to the lead-in and post-intervention WG-free
diets, and the intervention diet was monitored using food
diaries and monitoring whether plasma alkylresorcinol
concentrations remained within the expected range for a
WG-free diet. Subjects were asked to note down any possible
WG foods they ate during these periods. During the interven-
tion phases, subjects were also asked to note the amount of all
non-water beverages consumed, as well as any extra foods
eaten and physical activity. Any food, including bread, remain-
ing from the intervention diet was weighed and recorded to
determine exact food intake. Beverages, extra food and
remaining study foods were used for the quantification of
overall nutrient intake during the study.
Nutrient intake during the intervention diet periods was
estimated using a nutrient composition database program
(Genesis; ESHA Research, Salem, OR, USA) using data from
the Swiss nutrient composition tables. T
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Analytical methods
Plasma. Plasma was separated from blood by centrifugation
at 1000g for 10 min at 48C. Plasma total, HDL- and LDL-
cholesterol, TAG, glucose and C-reactive protein (CRP) were
analysed using enzymatic kits in an XPAND autoanalyser
(kits and instrument from Dade Behring, Du¨dningen,
Switzerland). Homocysteine was analysed by HPLC using a
kit (Bio-Rad AG, Reinach, Switzerland)(33). Betaine was ana-
lysed by isotope dilution liquid chromatography–MS/MS(27).
Alkylresorcinols were extracted by liquid–liquid extraction,
purified by mixed-mode anion-exchange solid-phase extrac-
tion and analysed by GC–MS according to the method of
Landberg et al.(34).
Faeces. Faecal samples were collected into Stomacher
bags (Seward Limited, Worthing, West Sussex, UK), and kept
at 48C before collection by the study centre, where they
were stored at 2408C. Faecal dry weight was determined
after freeze-drying for 48 h. Faecal water was produced
according to the method of Klinder et al.(35), where two
times (w/v) of distilled water (with 3 mM-sodium azide to
prevent microbial growth) was added to the sample in a
Stomacher bag and mixed using a Stomacher mixer (Seward
Limited) for 2 min. If homogenisation was not complete, this
was performed manually, and the samples were remixed
using the Stomacher mixer. A 20 ml aliquot was removed
into an ultracentrifuge tube, and tubes were centrifuged at
35 000 g for 120 min at 48C. The supernatant was divided
into aliquots for further analysis. Faecal water pH was deter-
mined using a pH probe.
Wet faeces were divided into aliquots before processing for
faecal water and frozen at 2808C before microbial analysis by
quantitative PCR. Details of this procedure and probes used
are provided in the supplementary material available at
http://www.journals.cambridge.org/bjn. Total bacteria, Bac-
teroides, Bifidobacterium, Clostridium coccoides, Clostridium
leptum, Enterobacteria, Enterococcus and Lactobacillus
groups were quantified. These groups represent the phyla
that make up the majority of the gut microbiota. During the
intervention diet periods, subjects were asked each day to
note down how many times they had passed stools. These
data over 14 d were used to determine stool frequency
(stools/d) over each dietary period.
Statistical analyses
All outcomes were analysed using ANCOVA in a mixed model
setting where diet effects were examined using diet, period,
baseline and other covariates as fixed effects and subject as
a random effect. No carry-over effect was assumed. For the
analysis of faecal bacterial counts, those below the detection
limit were set to the detection limit (106 colony-forming
units/g) for the purpose of analysis. Bacterial counts were
then log-transformed and analysed using ANCOVA as above.
In addition, ANOVA was used with repeated measures in
order to assess the effect of diets over time.
All analyses were conducted on the seventeen completed
subjects only. Furthermore, no correction of significant level
was employed to adjust for the multiple testing of data
because of the exploratory nature of the hypotheses studied.
Therefore, unadjusted P values are reported, and the results
are considered significant if P,0·05 (trends reported if
P,0·2).
Statistical analyses were performed using NCSS for
Windows 2007 (Kaysville, UT, USA) and SAS (version 9.1;
SAS Institute, Cary, NC, USA).
Results
Subjects
Of the twenty-two subjects recruited to the study, five subjects
withdrew prematurely and seventeen subjects completed the
study. One subject dropped out due to an inability to
comply with the intervention diet (consumed ,50 % of their
estimated daily energy requirement), one subject dropped
out due to an unrelated illness and three other subjects
dropped out due to unexpected travel commitments during
the study. Baseline (after the lead-in period) plasma lipid, glu-
cose, CRP, homocysteine, betaine and alkylresorcinol concen-
trations did not differ between the two different arms of the
study (Table 2).
Food intake and compliance
The average energy intake was 8·4 MJ/d (2013 kcal/d) for the
WG diet and 8·6 MJ/d (2064 kcal/d) for the RG diet (Table 3).
There was no difference in overall energy, protein, fat or
carbohydrate intake between the two diets. However, total
fibre, cereal fibre, alkylresorcinol and cereal betaine intake
were higher during the WG diet (all P,0·001). The average
recorded WG intake during the WG diet was 151 g/d. No sub-
jects reported eating WG foods during the lead-in or post-
intervention periods, nor during the RG diet. Total plasma
alkylresorcinols for all subjects were below 82 (median
24) nmol/l during the lead-in and post-intervention periods
with the exception of one subject. This subject had an alkyl-
resorcinol concentration of 238 nmol/l one week after the RG
diet, suggesting that they had recently consumed WG wheat
before the sampling. Overall, the alkylresorcinol concentrations
during the lead-in and post-intervention diet periods were not
significantly different from the RG diet. This indicates that all
subjects successfully avoided WG wheat and rye as requested
with the exception of one subject at one time point. The
C17 : 0-to-C21 : 0 homologue ratio, which can distinguish
between a wheat- and a rye-based diet(36), was consistent with
the consumption of wheat-based products.
Plasma biomarkers
After 1 week, plasma TAG were higher on the WG diet com-
pared with the RG diet (1·09 v. 0·89 nmol/l; P¼0·05). After
2 weeks on the WG diet, there was a trend for a decrease in
total cholesterol by 3 % and LDL-cholesterol by 9 % compared
with the RG diet (both P¼0·09), while there was no longer
any difference between the two diets for plasma TAG. There
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was no change in plasma HDL-cholesterol, glucose, CRP or
homocysteine at 1 or 2 weeks after starting the WG diet, com-
pared with equivalent time points for the RG diet (Table 4).
Plasma betaine was elevated after 1 week of the WG diet
(P¼0·01), and concentrations had dropped by 2 weeks, with
a less marked difference between the two diets (P¼0·08).
Mean baseline concentration of plasma alkylresorcinols, bio-
markers of WG wheat and rye intake, was 46 (median 34;
range 6–144) nmol/l, which was expected as the subjects
were recruited as low-WG consumers. Plasma alkylresorcinols
were increased by an average of 14·5 times after 1 week of the
WG diet, remaining at approximately the same concentration
after 2 weeks (both P,0·001). During the RG diet, plasma
alkylresorcinols were moderately increased to 44–47 nmol/l
(P,0·05 compared with after the lead-in and post-interven-
tion periods), due to the high amount of refined-wheat
products contained in the diet. Plasma alkylresorcinol
concentrations returned to baseline values after 1 week of
the post-intervention period (P.0·6). The mean of total
alkylresorcinol concentrations during the post-intervention
period was 28 (median 24; range 7–82) nmol/l (excluding
one outlier), while the mean of total alkylresorcinol concen-
trations during the RG diet was 45 (median 41; range
25–98) nmol/l. Alkylresorcinol concentrations returned to
baseline values after 1 week of the WG-free, post-intervention
diet (after lead-in, mean 23 (median 15; range 7–67) nmol/l;
1 week post-intervention, mean 38 (median 32; range
14–79) nmol/l; 2 weeks post-intervention, mean 30 (median
26; range 8–82) nmol/l (P,0·01)), demonstrating that there
is no clear carry-over effect on plasma alkylresorcinols
1 week after stopping eating WG.
During the postprandial challenge, there were no differ-
ences between the two diets for TAG or glucose (Figs. 2 and
3, respectively). After the WG breakfast, plasma betaine was
elevated compared with the RG breakfast at comparative
time points (Fig. 4). Betaine was increased by 18 % from base-
line at 120 min after the WG meal (P,0·01). Betaine was also
increased from baseline at 60 min after the RG meal (P,0·05),
even though the betaine concentration in maize is low(27).
Plasma alkylresorcinols increased moderately from fasting
concentrations, and were always different from the same
time points during the RG meal (Fig. 5). Although energy
intake was similar during both diets, there was a trend for
the WG diet to lead to 0·5 kg weight loss over the 2-week
intervention period, compared with the RG diet (P¼0·19).
Faecal parameters
There was no overall change in the faecal microbiota popu-
lation, with the exception of the C. leptum group, which
was slightly increased after the WG diet (P¼0·02), and a
trend for an increase in Enterococcus spp. (P¼0·06)
(Table 5). Inter-subject variability was large for total bacteria
and all bacterial species analysed. There was a trend for a
decrease in faecal water pH on the WG cereal diet compared
with the RG diet (7·14 v. 7·38; P¼0·063 for the difference in
change from baseline), while stool frequency was increased
Table 2. Baseline characteristics of subjects who completed the study
(Mean values with their standard errors)
Females (n 11) Males (n 6)
Baseline RG Baseline WG Baseline RG Baseline WG
Mean SEM Mean SEM Mean SEM Mean SEM
Age (years) 34·1 3·0 34·1 3·0 36·5 4·2 36·5 4·2
Wt (kg) 63·4 2·2 63·8 2·4 78·2 3·1 78·3 3·0
BMI (kg/m2) 23·1 0·8 23·2 0·9 24·5 0·6 24·5 0·6
Plasma total cholesterol (mmol/l) 4·7 0·2 4·6 0·2 4·5 0·5 4·5 0·4
Plasma HDL-cholesterol (mmol/l) 1·7 0·2 1·7 0·1 1·4 0·1 1·4 0·0
Plasma LDL-cholesterol (mmol/l) 2·6 0·2 2·5 0·2 3·0 0·5 2·9 0·4
Plasma TAG (mmol/l) 1·0 0·2 1·0 0·1 0·8 0·1 0·7 0·1
Plasma glucose (mmol/l) 4·9 0·1 4·9 0·1 5·1 0·1 5·1 0·0
Plasma CRP (mg/l) 5·6 2·0 3·0 1·0 1·7 0·2 2·2 0·9
Plasma homocysteine (mmol/l) 10·7 1·0 10·9 0·9 10·9 1·3 10·7 1·3
Plasma betaine (mmol/l) 32·3 4·4 33·4 5·8 59·4 10·6 49·8 3·6
Plasma total alkylresorcinols (nmol/l) 46·2 10·8 25·4 3·9 74·5 17·9 48·3 10·6
RG, refined grain; WG, whole grain; CRP, C-reactive protein.
Table 3. Actual nutrient intake during the two intervention diet periods
(Mean values and standard deviations)
Refined-
grain diet
Whole-grain
diet
Mean SD Mean SD P
Energy
kJ 8638 881 8421 1003 0·51
kcal 2064 210 2013 240 0·51
Protein (g) 78 8 80 9 0·45
Fat (g) 65 8 68 10 0·42
Carbohydrate (g) 295 30 276 33 0·08
Total fibre (g) 19 2 32 3 ,0·001
Cereal fibre (g) 8 1 22 3 ,0·001
Total cereal intake (g) 271 38 259 34 0·34
Total whole-grain intake
(g DM)
0 0 151 15 ,0·001
Alkylresorcinols (mg) 5 1 62 10 ,0·001
Betaine from cereals (mg) 119 15 231 28 ,0·001
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(1·40 v. 0·96 stools/d; P,0·0001). Two subjects noted that they
had problems with constipation during the RG diet.
Discussion
WG cereals are recommended as an important part of a
healthy diet, and at least three servings (48 g)/d are specifically
recommended in the Dietary Guidelines for Americans 2005,
with up to 6 oz (170 g) recommended each day(30), while at
least 75 g/10 MJ are recommended for adults in Denmark(37).
In the present study, we designed a diet that used cereal
grains as the main source of carbohydrates for each meal in
order to see likely responses to a WG cereal diet compared
with a RG diet over a relatively short time period (2 weeks).
The two diets were well matched for overall energy content
and macronutrient composition, and there was no difference
between actual macronutrient intakes between the two diets,
with the exception of fibre. The fibre content of the WG
cereal diet, 34 g/d, is at the upper range of Swiss nutritional
recommendations, while the RG diet (19 g/d) was the same
Table 4. Plasma clinical chemistry measurements and the effect of the whole-grain (WG) diet compared with the
refined-grain (RG) diet
(Mean values with their standard errors and 95 % confidence intervals)
RG WG RG–WG*
Mean SEM Mean SEM Mean 95 % CI
Week 1
Total cholesterol (mmol/l) 4·12 0·14 4·08 0·17 0·03 20·17, 0·24
LDL-cholesterol (mmol/l) 2·39 0·14 2·25 0·15 0·15 20·13, 0·43
HDL-cholesterol (mmol/l) 1·62 0·07 1·57 0·07 0·08 20·05, 0·22
TAG (mmol/l) 0·89 0·10 1·09 0·15 20·27† 20·54, 0·00
Glucose (mmol/l) 4·87 0·07 4·83 0·10 20·03 20·24, 0·17
C-reactive protein (mg/l) 2·90 0·82 3·10 0·85 0·29 20·92, 1·49
Homocysteine (mmol/l) 8·83 0·68 8·87 0·61 20·04 20·65, 0·58
Betaine (mmol/l) 37·46 3·81 47·45 5·38 210·17‡ 217·60, 22·73
Total alkylresorcinols (nmol/l) 46·7 4·2 333·9 39·5 2291·6§ 2367·0, 2216·3
Week 2
Total cholesterol (mmol/l) 4·12 0·14 3·91 0·12 0·18k 20·03, 0·38
LDL-cholesterol (mmol/l) 2·31 0·12 2·16 0·10 0·18k 20·04, 0·40
HDL-cholesterol (mmol/l) 1·62 0·10 1·59 0·07 0·07 20·06, 0·20
TAG (mmol/l) 0·97 0·10 1·00 0·12 20·09 20·28, 0·09
Glucose (mmol/l) 5·07 0·07 5·06 0·07 20·03 20·19, 0·14
C-reactive protein (mg/l) 3·01 0·90 3·38 0·92 20·01 22·00, 1·97
Homocysteine (mmol/l) 8·57 0·60 8·78 0·62 20·16 20·62, 0·29
Betaine (mmol/l) 36·72 3·47 41·74 4·49 25·07k 210·86, 0·71
Total alkylresorcinols (nmol/l) 43·5 4·2 357·4 39·7 2318·4§ 2391·7, 2245·0
* Corrected for baseline. Statistical analyses were corrected for treatment order, age, sex, BMI and baseline concentrations.
†P¼0·05.
‡P¼0·01.
§P,0·0001.
kP,0·1.
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Fig. 2. Plasma TAG concentrations monitored for 240 min after a whole-grain
breakfast (shredded wheat) or a refined-grain breakfast (cornflakes). The
interventions were taken against a background of a diet rich in whole grains
or refined grains. Values are means, with standard errors represented by ver-
tical bars. , Refined-grain diet; , whole-grain diet.
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Fig. 3. Plasma glucose concentrations monitored for 240 min after a whole-
grain breakfast (shredded wheat) or a refined-grain breakfast (cornflakes).
The interventions were taken against a background of a diet rich in whole
grains or refined-grains. Values are means, with standard errors represented
by vertical bars. , Refined-grain diet; , whole-grain diet.
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as the normal intake among the French-speaking Swiss popu-
lation (M. Vidal et al., unpublished results), so the RG diet
cannot be defined as being especially low in fibre. The
intake of other WG-related nutrients measured, betaine and
alkylresorcinols, was at the upper range of estimated intakes
from cereal foods(38,39).
Some studies have found that a WG-rich diet does decrease
plasma total and LDL-cholesterol(9,11,40), and in the context of
the short duration of the intervention, a trend for a decrease in
both total and LDL-cholesterol is remarkable, especially as all
subjects were apparently healthy and normocholesterolaemic
at baseline. The possible reason why some well-executed
studies have not found an effect of WG on plasma cholesterol
is the type of control used. For example, a WG diet has been
compared with a low-WG diet(21) or subjects have added WG
foods to their diet rather than replacing RG foods as
recommended(22,23). These results point to the use of a well-
defined RG control diet being important for studying the
effects of a WG diet. The trend for a reduction in plasma
cholesterol in the present study lends further support to the
repeated findings in epidemiological studies that diets high
in WG cereals compared with those low in WG cereals are
protective against CVD(2).
No differences between diets were seen for plasma TAG,
glucose, CRP or homocysteine. While some studies have
found an effect of WG foods on these markers such as
CRP(41), it is possible that WG foods have a limited or no
effect in subjects where the biomarkers are at normal concen-
trations in healthy subjects. In the case of glucose, specific
challenge tests may be needed to observe the effects on glu-
cose metabolism, as for a recent study which has found that
a WG-based evening meal can improve glucose metabolism
the morning afterwards(42).
Some WG cereals, notably wheat and rye, are good sources
of dietary betaine(27), and it has been suggested to be one of
the beneficial components of WG foods(28), yet apparently
little research has been done on the effect of a WG cereal-
rich diet on plasma betaine concentrations. Betaine is a
methyl donor that is reported to have many metabolic func-
tions(43), most notably as an osmolyte and as a donor of a
methyl group in the conversion of homocysteine to methion-
ine. Betaine has been found to lower homocysteine in
humans(44), though estimated dietary betaine intake was not
associated with lower plasma homocysteine in women in an
epidemiological setting(45). Higher concentrations of plasma
betaine were associated with lower non-HDL-cholesterol,
TAG, BMI, body fat percentage, waist circumference(29) and
markers of inflammation(46), though betaine intake has not
been associated with decreased CVD(47). This highlights the
importance of distinguishing between greater betaine intake
and elevated plasma betaine, as only the latter has been
associated with potential benefits. Elevated plasma homocys-
teine has been associated with increased CVD risk and
increased markers of CVD risk (e.g. raised blood pressure
and elevated serum lipids(48,49)), and association with reduced
risk CVD has been found with WG cereal intake(2,14). The
elevation of plasma betaine after 1 week in the present
study was relatively small, though none of the subjects had
noticeably low betaine concentrations at baseline
(,18mmol/l)(50), and the RG diet was not notably low in
betaine or free choline (the direct metabolic precursor of
betaine)(27). Additionally, plasma betaine concentrations are
regarded as being under strict metabolic control(51). Homocys-
teine concentrations were not affected during this interven-
tion, though no subjects had notably elevated homocysteine
concentrations (.15mmol/l). During the postprandial chal-
lenge, plasma betaine, while being elevated compared with
the RG diet at time 0, was further elevated after 120 min,
suggesting a more important transient increase in plasma
betaine, before plasma clearance. Betaine has previously
been found to peak in plasma at 120–240 min post-dose
after a high betaine meal(52), and at 40–80 min post-dose
after feeding 1–6 g of pure betaine(53). The estimated dose of
betaine from the WG wheat breakfast cereal in the present
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Fig. 4. Plasma betaine concentrations monitored for 240 min after a whole-
grain breakfast (shredded wheat) or a refined-grain breakfast (cornflakes).
The interventions were taken against a background of a diet rich in whole
grains or refined grains. Values are means, with standard errors represented
by vertical bars. a,b,y,z Time points within the same diet with unlike letters
were significantly different (P,0·05). All time points between diets were sig-
nificantly different (P,0·05). , Refined-grain diet; , whole-grain diet.
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Fig. 5. Plasma alkylresorcinol concentrations monitored for 240 min after a
whole-grain breakfast (shredded wheat) or a refined-grain breakfast
(cornflakes). The interventions were taken against a background of a diet
rich in whole grains or refined grains. Values are means, with standard
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study was 53 mg, about ten times less than that used in the test
meal by Atkinson et al.(52) and 20–120 times less than the pure
betaine used by Schwab et al.(53), and more closely reflects the
impact of a standard breakfast serving on plasma betaine. The
differences found suggest that dose and matrix may have a
small impact on pharmacokinetics. After 2 weeks, there was
no difference between the two diets for plasma betaine. This
may in part be explained by the fact that little of the body’s
betaine appears to be stored in plasma with rapid accumu-
lation (up to twenty times that of plasma concentrations) in
the liver and kidneys(54,55). Previously, it has been reported
that betaine may increase plasma LDL and TAG at the same
time as decreasing plasma homocysteine(56). This is suggested
to be due to the increased supply of betaine, sparing choline
for the production of VLDL particles, enabling better lipid
transport from the liver and, consequently, a transient increase
in plasma lipids(57). In the present study, the increase in
betaine at 1 week was mirrored by an increase in TAG, with
both dropping after 2 weeks. As there was no difference in
lipid intake between the diets that would explain the TAG
increase after 1 week, the possibility of a link with increased
dietary betaine intake is intriguing.
Plasma alkylresorcinols have been proposed to be bio-
markers of WG wheat and rye intake(58), with several studies
now indicating a strong correlation between WG wheat and
rye intake, and their presence in the plasma(31,59). Not surpris-
ingly in the present study, plasma alkylresorcinols were con-
siderably elevated compared with the RG diet. As refined
wheat still contains low concentrations of alkylresorcinols(32),
low concentrations were still present in the plasma during the
non-WG and RG diet periods. Presently, there are little data on
the plasma concentrations of alkylresorcinols on a low/non-
WG cereal diet, and results from the present study suggest
that concentrations of total alkylresorcinols below 60 nmol/l
probably indicate a diet not containing WG. Additionally,
they confirm that plasma alkylresorcinols are responsive to
WG wheat and rye in the diet, as indicated by the sharp
increase in concentration on the WG intervention diet,
though the amount of alkylresorcinols consumed in this diet
is at the upper end of what would be consumed as part of a
‘normal’ diet(39).
During the postprandial study, there was a relatively small
increase in plasma alkylresorcinols throughout the 240 min
period measured. Only one study has looked at the pharma-
cokinetics of alkylresorcinols in human subjects, after a rye
bran-based meal, and found that the Tmax occurs about
168 min(60), whereas the concentration still appears to be
increasing at 240 min in the present study. In a study on
pigs habitually fed a rye bran-containing diet, plasma alkyl-
resorcinols remained elevated between 120 and 360 min(61),
and found that there was a marked difference in alkylresorci-
nol pharmacokinetics for habitual feeding and an acute meal.
The data collected in the present study over 240 min would
suggest that pharmacokinetics for alkylresorcinols in human
subjects are also different if measured against the background
of a habitual diet containing WG wheat or rye.
The trend for decreasing weight on the WG diet was unex-
pected, as most intervention studies addressing the question
of weight loss or maintenance and WG diets have found no
effect on total weight loss(20,40,41), though epidemiological evi-
dence finds that WG intake is associated with lower BMI(62,63),
and one non-peer reviewed study has reported 0·9–1·4 kg
weight loss on a WG diet compared with an energy-matched
RG diet over 4–6 weeks(64). The subjects in the present study
were all normal weight (BMI ,26 kg/m2) except for one sub-
ject who had a BMI of 29·6 kg/m2, making the trend for a
0·5 kg change in weight more remarkable.
Due to the inherently high fibre content of WG cereals com-
pared with their refined counterparts, it has been hypoth-
esised that WG cereals may play a role in modulating
intestinal microbiota and alter intestinal transit. Some studies
have found that WG wheat and/or rye diets alter faecal chem-
istry, increasing SCFA concentrations and decreasing faecal
pH(18). The increase in stool frequency was expected, and
WG cereals have previously been demonstrated to be effective
for improving stool frequency in constipated subjects(65). One
study compared the effects of a WG wheat breakfast cereal
with a wheat bran breakfast cereal over 3 weeks on faecal
Table 5. Faecal microbiota population measurements during the two dietary interventions,
and the effect of the whole-grain (WG) diet compared with the refined-grain (RG) diet*
(Mean values with their standard errors and 95 % confidence intervals; log10 colony-forming
units/g fresh weight)
RG WG RG–WG
Mean SE Mean SE Mean 95 % CI
Total bacteria 10·03 0·3 10·39 0·2 20·37 21·16, 0·41
Bifidobacterium 8·93 0·4 9·30 0·3 20·56 21·62, 0·49
Lactobacillus 6·82 0·2 6·66 0·1 0·01 20·45, 0·47
Enterobacteria 7·31 0·2 7·22 0·2 0·14 20·04, 0·32
Enterococcus 6·03 0·0 6·18 0·1 20·23† 20·47, 0·01
Clostridium coccoides 9·64 0·3 9·89 0·3 20·42 21·15, 0·31
Clostridium leptum 9·24 0·3 10·05 0·1 20·82‡ 21·51, 20·13
Bacteroides 8·43 0·3 8·72 0·3 20·31 21·38, 0·76
* Faecal samples were spot collections of the first bowel movement of the day. Statistical analyses per-
formed on log-transformed data were corrected for baseline bacterial population counts, treatment order,
age, sex and BMI.
†P¼0·056.
‡P¼0·023.
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microbiota populations, and found that bifidobacteria and
lactobacilli/enterococci populations increased with WG
wheat(19), and a similar study has found that WG maize break-
fast cereal increased faecal bifidobacteria populations after
3 weeks(66). In the relatively short duration of the present
study, there was only a weak effect (less than one log
change) on the faecal microbiota, with a trend for an increase
in Enterococcus, as for Costabile et al.(19) and a small increase
in the C. leptum group. The C. leptum subpopulation is
known to contain a number of bacterial species adapted for
utilising fibre as a substrate and producing butyrate(67).
Abnous et al.(68) found that C. leptum populations increased
in rats fed either wheat or oat bran. Vitaglione et al.(69)
recently proposed that the phenolic compounds bound in
the dietary fibre complex may also modify the intestinal
environment which may play a role in the gut microbiota
population, and clostridia are associated with the metabolism
of phenolic compounds(70). The observed trend for a decrease
in faecal water pH with the WG diet fits with the increase in
butyrate-producing bacteria. The 2-week intervention period
was probably too short to see a ‘full’ effect of the two diets,
and most studies focusing on faecal microbiota last for at
least 3 weeks(19). Nevertheless, the fact that small changes in
faecal microbiota (and by implication, intestinal microbiota)
were already evident after 2 weeks suggests that longer-term
WG-based diets could have an effect on microbiota popu-
lations. Follow-up studies are required to investigate the
long-term effects of a WG-rich diet on faecal microbiota
populations.
The presence of many ‘trend’ results in the present study
suggests that more significant results could have been
obtained with a higher number of subjects. The daily
amount of WG provided during the present study was high
compared with usual intakes of about 16–25 g/d(71,72) and
minimum recommended intakes of 48–75 g(30,37), but were
well tolerated by the subjects, with no complaints noted
about the WG component of the diets. This may be in part
due to the fact that all WG foods were commercially available
and so aimed at being palatable for the consumer rather than
for use in a scientific study. The use of WG-based foods as the
base for the carbohydrate component of a normal diet appears
to be a good strategy for increasing WG intake, and appears to
provide benefits for CVD risk markers, even in healthy
subjects.
Most studies on the effects of WG cereals on biomarkers of
disease have focused on specific types of grains (e.g. barley
and brown rice(9,12,13), rye(8,15,16,73), oats(40,74) and wheat(11)),
while studies using a variety of grains have generally not
found differences from the control(21,22). Those studies using
a mixture of WG have attempted to replicate what could be
possible with a ‘normal’ mixed diet, which has led to less con-
trol of WG intake during the control group/arm. In the present
study, a mixed WG diet, containing mostly wheat-based pro-
ducts, found results on lowering LDL-cholesterol, a result
that has been found previously for longer-term interventions
based on barley and brown rice(9), oats(40,74) and wheat(11).
It would appear then that the effect of WG cereals on lowering
cholesterol does not necessarily need to be considered as
associated specifically with those cereals high in soluble
fibre (oats and barley), but could be ascribed to a diet that
is generally high in WG cereals. While the reductionist
approach naturally leads to the testing of individual cereals
and cereal fractions to elucidate the key components respon-
sible for observed effects, it is also important to conduct
studies on mixed diets that are more likely to reflect what
could be consumed on a regular basis and are likely to be
easier for long-term consumption. The present study, while
providing a high amount of WG/d, does demonstrate that a
diet based on mixed commercially available WG products
can lead to a reduction in LDL-cholesterol over a relatively
short period of time.
Conclusions
The present study found a tendency for an effect of a WG diet
on plasma cholesterol, further supporting the epidemiological
evidence that WG cereals decrease the risk of CVD. The find-
ing that plasma betaine is also elevated due to a WG diet pre-
sents new possibilities for mechanisms of how WG cereals
may have protective effects(28), and adds weight to the
hypothesis that the benefits of WG cereals are beyond being
a source of fibre in the diet(7). Future studies are needed to
confirm that these results can be repeated with lower amounts
of WG and over longer time periods.
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